04:11 PM EDT, 03/26/2025 (MT Newswires) -- Clay B Siegall, Director, President and CEO, on March 26, 2025, executed a purchase for 137,100 shares in Immunome ( IMNM ) for $999,459. Following the Form 4 filing with the SEC, Siegall has control over a total of 806,736 common shares of the company, with 806,736 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1472012/000141588925009017/xslF345X05/form4-03262025_080357.xml